Sale!

EIF2B1 Gene Leukoencephalopathy with Vanishing White Matter Genetic Test

Original price was: $700.Current price is: $500.

-29%

The EIF2B1 Gene Leukoencephalopathy with Vanishing White Matter NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the EIF2B1 gene responsible for vanishing white matter disease. This progressive neurological disorder affects the brain’s white matter, leading to motor and cognitive decline. Using Next-Generation Sequencing technology, this test provides comprehensive analysis of the EIF2B1 gene to detect pathogenic variants. The test is essential for individuals experiencing neurological symptoms, those with family history of leukoencephalopathy, or for prenatal diagnosis. Results help guide treatment decisions, provide prognostic information, and enable genetic counseling for family planning. The test costs $500 USD with genetic counseling included.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

EIF2B1 Gene Leukoencephalopathy with Vanishing White Matter NGS Genetic DNA Test

Comprehensive Genetic Testing for Progressive Neurological Disorders

The EIF2B1 Gene Leukoencephalopathy with Vanishing White Matter NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics. This advanced test specifically targets mutations in the EIF2B1 gene, which plays a critical role in protein synthesis regulation and cellular stress response. Vanishing white matter disease is a rare, progressive leukoencephalopathy that primarily affects the brain’s white matter, leading to gradual neurological deterioration.

What Does This Test Measure?

Our comprehensive NGS genetic test analyzes the entire coding region of the EIF2B1 gene to identify:

  • Pathogenic variants and mutations in the EIF2B1 gene
  • Single nucleotide polymorphisms (SNPs) associated with disease
  • Insertions, deletions, and copy number variations
  • Compound heterozygous mutations
  • Novel variants of uncertain significance

The test utilizes state-of-the-art Next-Generation Sequencing technology, providing unparalleled accuracy and comprehensive coverage of the EIF2B1 gene region.

Who Should Consider This Test?

This genetic test is recommended for individuals presenting with:

  • Progressive neurological symptoms including ataxia and spasticity
  • Cognitive decline or developmental regression in childhood
  • Episodes of neurological deterioration following minor head trauma or fever
  • Family history of leukoencephalopathy or white matter disorders
  • Abnormal MRI findings showing diffuse cerebral white matter abnormalities
  • Unexplained progressive motor function loss
  • For prenatal diagnosis in families with known EIF2B1 mutations

Clinical Benefits of Genetic Testing

Undergoing EIF2B1 genetic testing provides numerous clinical advantages:

  • Accurate Diagnosis: Confirms or rules out vanishing white matter disease
  • Prognostic Information: Helps predict disease progression and severity
  • Treatment Guidance: Informs management strategies and therapeutic approaches
  • Genetic Counseling: Enables informed family planning decisions
  • Early Intervention: Facilitates timely management of symptoms
  • Research Contribution: Advances understanding of rare neurological disorders

Understanding Your Test Results

Our comprehensive genetic counseling service helps you interpret your results:

  • Positive Result: Indicates presence of pathogenic EIF2B1 mutations confirming diagnosis
  • Negative Result: Suggests vanishing white matter disease is unlikely, though other genetic causes may be considered
  • Variant of Uncertain Significance: Requires further clinical correlation and family studies
  • Carrier Status: Identifies individuals who may pass mutations to offspring

All results are reviewed by board-certified geneticists and neurologists to ensure accurate interpretation and appropriate clinical recommendations.

Test Pricing and Details

Test Component Details
Test Name EIF2B1 Gene Leukoencephalopathy with Vanishing White Matter NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Methodology Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

Before testing, we recommend:

  • Complete clinical history documentation
  • Genetic counseling session to create detailed family pedigree
  • Discussion of testing implications and potential outcomes
  • Informed consent process
  • Neurological evaluation when indicated

Nationwide Testing Availability

We provide comprehensive genetic testing services across the United States with convenient locations in major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and neurological specialists ensures you receive expert care regardless of your location.

Take the Next Step Toward Diagnosis

If you or a family member are experiencing symptoms suggestive of vanishing white matter disease, don’t delay in seeking genetic testing. Early diagnosis can significantly impact management strategies and quality of life. Our team of genetic specialists is ready to guide you through the testing process and provide comprehensive support.

Call us today at +1(267) 388-9828 to schedule your genetic counseling session and testing appointment. Take control of your neurological health with advanced genetic diagnostics from General Genetics Corporation.